WSFS
IONS icon

Wilmington Savings Fund Society’s Ionis Pharmaceuticals IONS Stock Holding History

Wilmington Savings Fund Society’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-92
Closed -$3.22K – 2112
2024
Q4 		$3.22K Hold
92
– – ﹤0.01% 1868
2024
Q3 		$3.69K Buy
+92
New +$4.28K ﹤0.01% 1832

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Wilmington Savings Fund Society's IONS Position: Q1 2025 in Review

Wilmington Savings Fund Society sold out of Ionis Pharmaceuticals (IONS) in Q1 2025, closing a stake of 92 shares — an estimated $3.22K sold.

Wilmington Savings Fund Society first reported a position in IONS in Q3 2024 and held it in 2 quarters. The position peaked at $3.69K in Q3 2024. 344 funds tracked by Wall St. Rank hold IONS as of Q1 2025.

  • Wilmington Savings Fund Society reported no remaining Ionis Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Wilmington Savings Fund Society sold 92 Ionis Pharmaceuticals shares in Q1 2025, an estimated $3.22K.
  • Wilmington Savings Fund Society first reported a position in Ionis Pharmaceuticals in Q3 2024 and held it in 2 quarters.
  • Wilmington Savings Fund Society's Ionis Pharmaceuticals position peaked at $3.69K in Q3 2024.
  • 344 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2025.

Based on Wilmington Savings Fund Society's 13F filing for Q1 2025, filed 8 May 2025.